000			05698cam a2200613Ia 4500
999			_c9562 _d9562
001			9562
003			ES-VaUE
005			20210512155501.0
006			m o d
007			cr un|---aucuu
008			201031s2021 si ob 000 0 eng d
017			_a1199127432 _a1204151204
020			_a9789811576393 ( _q) ( _qelectronic bk.)
020			_a9811576394 ( _q) ( _qelectronic bk.)
020			_z9811576386
020			_z9789811576386
024	7		_a10.1007/978-981-15-7639-3 _2doi
024	1		_aAU@ _b000068176372
040			_aEBLCP _beng _cEBLCP _dYDX _dUKAHL _dGW5XE _dSFB _dOCLCF _dOCLCO
050			_aRD93 _b.Z83 2021 EB
072		7	_aMJGD _2bicssc
072		7	_aMED027000 _2bisacsh
072		7	_aMJGD _2thema
082	0	4	_a617.5/85 _223
245	0	0	_aDiabetic foot ulcer : _ban update _cMohammad Zubair, Jamal Ahmad, Abida Malik, Mallikarjuna Rao Tallur, editors
250			_a1st ed. 2021
260			_aSingapore _bSpringer _c2021
300			_a1 online resource (361 p.)
336			_atext _btxt [ _2rdacontent]
337			_acomputer _bc [ _2rdamedia]
338			_aonline resource _bcr [ _2rdacarrier]
500			_aDescription based upon print version of record
504			_aIncludes bibliographical references
505	0		_aIntro -- Preface -- Contents -- About the Editors -- Contributors -- Part I: World Preview -- 1: Diabetic Foot Complications in Asia and European Continents -- 1.1 Introduction -- 1.1.1 Foot Ulceration Pathogenesis -- 1.1.2 Neuropathy -- 1.1.3 Peripheral Vascular Disease -- 1.1.4 Other Risk Factors -- 1.1.5 Ulceration Pathway -- 1.1.6 Sensory Loss Among the Patients -- 1.1.7 Charcot Neuroarthropathy -- 1.2 Overview of the Diabetic Foot Ulcer (DFU) -- 1.2.1 Diabetic Foot Ulcer (DFU) Burden in Asia -- 1.2.2 Diabetic Foot Ulcer (DFU) Burden in European Continents
505	8		_a1.3 Factors for Diabetic Foot Diseases in Asia and European Continents -- 1.3.1 Poverty and Hygiene -- 1.3.2 Sociocultural Practices -- 1.3.3 Ignorance -- 1.3.4 Environment and Other Related Factors -- 1.4 Evaluation of Diabetic Foot Infections (DFI) -- 1.4.1 Evaluation: Physical Examination -- 1.4.2 Evaluation: Laboratory Testing -- 1.4.3 Evaluation: Microbiology -- 1.5 Strategy for Prevention of Diabetic Foot Management -- 1.5.1 Education -- 1.5.2 Foot Care and Screening -- 1.5.2.1 Patient Care Pathway for a Screening of Patients for Diabetic Foot Complications
505	8		_a1.5.2.1.1 Screening Level 1: Initial Assessment -- 1.5.2.1.2 Screening Level 2: Further Assessment -- 1.5.2.1.3 Screening Level 3: Assessment with Vascular Surgeon -- 1.5.2.1.4 Algorithm for Diabetic Foot Complications Screening -- 1.5.2.2 Clinical Screening Tests -- 1.5.2.2.1 Sensation -- 1.5.2.2.2 The 10-g Monofilament -- 1.5.3 Government Intervention -- 1.5.4 Cost-Effectiveness of Prevention -- 1.6 Geographic Differences in Clinical Outcome -- 1.7 Conclusion -- References -- 2: Diabetic-Foot Complications in African and Antarctica Continents -- 2.1 Introduction
505	8		_a2.2 Pathophysiology of Foot Ulcers -- 2.3 Diabetic Foot Complications -- 2.3.1 Peripheral Neuropathy (PN) -- 2.3.2 Peripheral Arterial Diseases (PAD) -- 2.3.3 Diabetic Foot Ulceration (DFU) -- 2.3.4 Diabetic Foot Infection -- 2.3.5 Amputation -- 2.3.6 Mortality -- 2.4 Prevention -- 2.4.1 Step by Step (SbS) Foot Project -- 2.4.2 Train the Foot Trainer (TtFT) Project -- 2.5 Conclusion -- References -- 3: Diabetic-Foot Complications in American and Australian Continents -- 3.1 Introduction -- 3.2 Epidemiology of Diabetic Foot Complications -- 3.2.1 North America and Caribbean
505	8		_a3.2.2 South and Central America -- 3.2.3 Oceania -- 3.3 Geographic Variations in the Characteristics, Risk Factors, and Outcomes of DFU -- 3.3.1 Characteristics of DFU -- 3.3.2 Risk Factors for DFU -- 3.3.3 Outcomes of DFU -- 3.4 Epidemiology of Lower Limb Amputation -- 3.4.1 Incidence and Prevalence of Diabetes-Related LEA -- 3.4.2 Risk Factors for Diabetes-Related LEA -- 3.5 Diabetic Foot Infections -- 3.5.1 Microbial Epidemiology of Infection in Diabetic Foot Patients -- 3.5.2 Diagnosis and Assessing Severity of DFI -- 3.5.3 Antibiotic Treatment of DFI -- 3.6 Conclusion
520			_aThis book discusses essential aspects of diabetic foot ulcers, including evidence-based information on its pathogenesis and pathophysiology, as well as the molecular mechanisms and biomechanics of the diabetic foot. It also highlights the need for a multidisciplinary team to be involved in the management of diabetic patients with foot ulcers, and describes available and future tools for evaluating patients who are at risk. Exploring the main current therapies as well as the latest developments, future directions and potential new treatments, such as growth factors, stem cell therapy, alternative medicine and nanotechnology, the book is a valuable resource for clinicians and medical graduates but will also appeal to researchers working in the field
650		0	_aFoot- _xUlcers
650		0	_aDiabetes- _xComplications
650		7	_aDiabetes
650		7	_aHealth promotion.
650		7	_aNursing services- _xAdministration.
655		4	_aElectronic books
700	1		_aZubair, Mohammad
700	1		_aAhmad, Jamal ( _d1951-)
700	1		_aMalik, Abida
700	1		_aTalluri, Mallikarjuna Rao
776	0	8	_iPrint version: _aZubair, Mohammad. _tDiabetic Foot Ulcer : An Update, _dSingapore : Springer Singapore Pte. Limited,c2020 _z9789811576386
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-981-15-7639-3 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db